Oncorus Secures $57M Via Equity At 9% Discount - Oncorus Inc rdinary Shares (OTC:ONCR)

Oncorus Inc (NASDAQ: ONCR) prices of its underwritten public offering of 3 million common shares at $19 per share, raising $57 million in gross proceeds. The offer price represents a discount of 9% on the last close price of $20.97 on Thursday.
Underwriters have an option to purchase up to an additional 450,000 shares. The offering is expected to close on February 17
Jefferies, Evercore ISI, and Piper Sandler are acting as joint book-running managers for the offering.
Last month, Oncorus announced preclinical data for ONCR-177 that demonstrated potent and durable antitumor activity in multiple immune-competent tumor models.
Oncorus also announced building a viral immunotherapy clinical manufacturing facility in the U.S., with full operation commencing in early 2023.
Price Action: ONCR dipped 11.1% at $17.8 on the last check Friday.